Researchers at the George Washington University (GW) Cancer Center published their findings in Nature Communications on a form of genetic variation, called differential RNA splicing, which may have a role in tumor aggressiveness and drug resistance in African American men with prostate cancer.
Learn More
The George Washington (GW) Cancer Center is a collaboration between GW Hospital, The GW Medical Faculty Associates, and the GW School of Medicine and Health Sciences to expand GW’s efforts in the fight against cancer. The GW Cancer Center also partners with the Milken Institute School of Public Health at GW, and incorporates all existing cancer-related activities at GW, serving as a platform for future cancer services and research development.
Learn More
To address the multidimensional world of cancer, the GW Cancer Center offers an interdisciplinary approach to cancer research and treatment, pairing clinicians and population scientists with immunologists, geneticists, bioengineers, microbiologist, and policy experts to offer broad exploration of the disease.
We are pleased that you have selected the GW Cancer Center to provide your cancer care and support. The information found here will acquaint you with available information and resources.
The GW Cancer Center prides itself on being a leader in training and educating health professionals both locally and across the nation.
I don’t care what anybody says; when something like this comes up, it’s not only a test of your faith, it’s a test of endurance.
This was not supposed to happen. I am only 25 years old. I was supposed to learn I had some fat lobules or whatever it was that people my age have. Not breast cancer.
When a person is first diagnosed with cancer, they may not be in the best mindset, and yoga is a way to decompress.
WASHINGTON (Oct. 31, 2018) – Due to their broad antitumor activity that inhibits the function of microtubules, taxanes are common chemotherapeutic agents utilized for the management of multiple cancer types from breast to prostate. Unfortunately, the frequency of their use is equally matched by...
A host of representatives from throughout the George Washington University (GW) health care community joined GW Cancer Center leadership on Oct. 17 to cut the ribbon on a new multi-disciplinary cancer clinical space in the ground floor of the GW Medical Faculty Associates (GW MFA) Ambulatory...
Adam Friedman, MD, is the senior author of a study on the efficacy of nanoparticles in therapies for triple-negative breast cancer.
Dr. Adam Friedman joins breast cancer survivor Mariam Said to discuss side effects of cancer treatment and how the Supportive Oncodermatology Clinic at the GW Cancer Center is giving patients hope and resources for relief.
Norman Lee, PhD, is investigating the mechanism behind dysregulation splicing factor expression.
Katherine Chiappinelli, PhD, was awarded a prestigious grant from The G. Harold and Leila Y. Mathers Foundation.
Experts at the George Washington University (GW) School of Medicine and Health Sciences are available to comment on stories around Breast Cancer Awareness Month. Experts are available to comment on “stage 0” breast cancer diagnosis, personalized medicine, survivorship, trends in breast cancer care and treatment, and more.
It is within this context that the George Washington University (GW) School of Medicine and Health Sciences and its partners, the GW Medical Faculty Associates, GW Hospital, and GW's Milken Institute School of Public Health, have made a major investment to establish the GW Cancer Center.
By leveraging the existing talent across the GW campus under one umbrella, the additional recruitment of top-notch investigators, and our bold vision of "driving innovative research, personalized patient care, and cancer policy in the nation's capital," GW Cancer Center is poised in the fight against cancer. Read Full Magazine
